Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

Jorge E. Cortes, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio A. Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences